Income Statement - Contineum Therapeutics, Inc. (CTNM)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | |
|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 50.00 | 0.00 | 0.00 |
| Cost of revenue | 0.32 | 0.26 | 0.20 | 0.33 | |
| Gross profit | -0.32 | -0.26 | 50.00 | -0.33 | |
| Total operating expenses | 68.06 | 50.64 | 66.08 | 22.72 | 28.65 |
| Operating income | -68.06 | -50.89 | -16.08 | -22.72 | -28.65 |
| Non-operating income (net) | 8.08 | 8.64 | 39.25 | -1.53 | -0.35 |
| Income before tax | -59.98 | -42.26 | 23.17 | -24.25 | -29.00 |
| Income tax expense | 0.45 | 0.24 | |||
| Net income | -59.98 | -42.26 | 22.72 | -24.25 | -29.00 |
Show Quarterly Income Statement
Income Statement - Contineum Therapeutics, Inc. (CTNM)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 50.00 | 0.00 | 0.00 |
| Cost of revenue | 0.08 | 0.09 | 0.08 | 0.08 | 0.12 | 0.06 | 0.06 | 0.04 | 0.04 | 0.07 | 0.08 | |||
| Gross profit | -0.08 | -0.09 | -0.08 | -0.08 | 0.12 | -0.06 | -0.06 | -0.04 | 49.96 | -0.07 | -0.08 | |||
| Total operating expenses | 16.90 | 17.12 | 14.93 | 17.82 | 18.11 | -84.74 | 12.97 | 10.94 | 9.93 | 9.68 | 8.07 | 11.06 | 5.12 | 5.45 |
| Operating income | -16.90 | -17.12 | -14.93 | -17.90 | -18.11 | 84.74 | -12.97 | -10.94 | -9.93 | -9.68 | -8.07 | 38.94 | -5.12 | -5.45 |
| Non-operating income (net) | 2.45 | 1.96 | 2.14 | 1.86 | 2.12 | -99.31 | 2.71 | 1.94 | 1.51 | 1.75 | 1.70 | 3.36 | 0.29 | -2.06 |
| Income before tax | -14.46 | -15.16 | -12.79 | -16.04 | -15.99 | -14.57 | -10.27 | -9.01 | -8.42 | -7.93 | -6.37 | 42.29 | -4.82 | -7.51 |
| Income tax expense | -0.16 | -0.12 | 0.73 | |||||||||||
| Net income | -14.46 | -15.16 | -12.79 | -16.04 | -15.99 | -14.57 | -10.27 | -9.01 | -8.42 | -7.77 | -6.25 | 41.56 | -4.82 | -7.51 |